Diane S. Aschenbrenner is a former member of the faculty at Notre Dame of Maryland University and the Johns Hopkins University School of Nursing. She coordinates Drug Watch :
Am J Nurs. 2021 Nov 1;121(11):22. doi: 10.1097/01.NAJ.0000798992.09378.14.
The labeling of statins has been revised to remove the contraindication for use during pregnancy.For a select few women at high risk for cardiovascular events, statins may provide more benefit than risk, even during pregnancy. Most women do not have this high risk, however, and should still avoid statins during pregnancy.
他汀类药物的标签已被修改,以去除怀孕期间使用的禁忌症。对于少数患有心血管事件高风险的女性,即使在怀孕期间,他汀类药物也可能带来更多的益处而非风险。然而,大多数女性没有这种高风险,因此仍应避免在怀孕期间使用他汀类药物。